Shares of DuPont de Nemours, Inc. (NYSE:DD – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the seventeen research firms that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and twelve have given a buy recommendation to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $166.60.
Several brokerages have commented on DD. BMO Capital Markets upped their target price on shares of DuPont de Nemours from $75.30 to $180.00 and gave the company an “outperform” rating in a research report on Tuesday, May 5th. Citigroup lifted their price objective on DuPont de Nemours from $168.00 to $170.00 and gave the stock a “buy” rating in a research note on Thursday, July 2nd. The Goldman Sachs Group upped their price objective on DuPont de Nemours from $53.00 to $159.00 and gave the company a “neutral” rating in a report on Thursday, June 25th. UBS Group increased their target price on DuPont de Nemours from $175.00 to $178.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on DuPont de Nemours from $174.00 to $180.00 and gave the stock a “buy” rating in a report on Thursday, May 7th.
Institutional Inflows and Outflows
DuPont de Nemours Stock Down 0.2%
Shares of NYSE DD opened at $144.02 on Friday. DuPont de Nemours has a 1 year low of $90.92 and a 1 year high of $157.98. The firm’s 50-day moving average is $139.67 and its 200-day moving average is $141.01. The company has a current ratio of 2.43, a quick ratio of 1.82 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $19.45 billion, a PE ratio of 320.11, a price-to-earnings-growth ratio of 1.32 and a beta of 1.06.
DuPont de Nemours (NYSE:DD – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The basic materials company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.76 by $0.12. DuPont de Nemours had a net margin of 0.67% and a return on equity of 6.92%. The business had revenue of $1.82 billion during the quarter, compared to the consensus estimate of $1.81 billion. During the same period in the previous year, the firm posted $1.12 earnings per share. DuPont de Nemours’s revenue for the quarter was up 4.0% compared to the same quarter last year. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. Equities analysts expect that DuPont de Nemours will post 7.27 EPS for the current year.
DuPont de Nemours Cuts Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Monday, August 31st will be given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Monday, August 31st. DuPont de Nemours’s dividend payout ratio (DPR) is currently 533.33%.
About DuPont de Nemours
DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.
DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.
See Also
- Five stocks we like better than DuPont de Nemours
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.
